Satsuma Pharmaceuticals (NASDAQ:STSA) Announces Quarterly Earnings Results
Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating) issued its quarterly earnings data on Tuesday. The financial services provider reported ($0.49) EPS for the quarter, meeting the consensus estimate of ($0.49), MarketWatch Earnings reports. Shares of NASDAQ:STSA traded down $0.01 during trading on Thursday, reaching $3.78. The stock had a trading volume of 34,273 shares, compared to […]
Source: etfdailynews.com